Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

New compounds were made that are promising for prostate cancer therapy.

Blocking a protein called prostaglandin D2 might help treat hair loss.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Certain drugs can cause early hair growth in mice by affecting the nerves.

New compounds show promise as nonsteroidal treatments for hair loss.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Mutations in certain receptors can cause diseases and offer new treatment options.

Thyroid receptor β can help develop new drugs to treat hair loss.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

GLP-1 agonists may help treat certain skin conditions.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

GRF is not safe for tubal occlusion.

Geranylgeraniol from nutmeg may effectively treat hair loss, similar to finasteride and better than minoxidil.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

AHR ligands could treat inflammatory skin diseases.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.